Breast cancer genetics: What we know and what we need
- 1 May 2001
- journal article
- review article
- Published by Springer Nature in Nature Medicine
- Vol. 7 (5) , 552-556
- https://doi.org/10.1038/87876
Abstract
Breast cancer results from genetic and environmental factors leading to the accumulation of mutations in essential genes. Genetic predisposition may have a strong, almost singular effect, as with BRCA1 and BRCA2, or may represent the cumulative effects of multiple low-penetrance susceptibility alleles. Here we review high- and low-penetrance breast-cancer-susceptibility alleles and discuss ongoing efforts to identify additional susceptibility genes. Ultimately these discoveries will lead to individualized breast cancer risk assessment and a reduction in breast cancer incidence.Keywords
This publication has 49 references indexed in Scilit:
- Frequency and Carrier Risk Associated with Common BRCA1 and BRCA2 Mutations in Ashkenazi Jewish Breast Cancer PatientsAmerican Journal of Human Genetics, 1998
- BRCA1 physically associates with p53 and stimulates its transcriptional activityOncogene, 1998
- BRCA1Mutations in Women Attending Clinics That Evaluate the Risk of Breast CancerNew England Journal of Medicine, 1997
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Transcriptional activation by BRCA1Nature, 1996
- BRCA1 mutations in young women with breast cancerThe Lancet, 1996
- Unusual case of Smith‐Lemli‐Opitz syndrome “type II”American Journal of Medical Genetics, 1995
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994
- The genetic epidemiology of BRCA1The Lancet, 1994
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994